Bette Kim is a Cardiology physician affiliated with NYU Langone Health. OpenAlex indexes 33 publications with 2,046 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
425 W 59th St
9-C
New York, NY 100191104
Telephone
212-492-5550Provider last certified this registry record 8 May 2025.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- Novo Nordisk IncProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.3%Statin18.8%Atorvastatin Calcium60%Rosuvastatin Calcium37%Zocor3%Part D<11 patientsBeta blocker14.1%Metoprolol Succinate71%Atenolol16%Carvedilol9%Metoprolol Tartrate5%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
9.9%SGLT2 inhibitor4.5%Jardiance57%Farxiga43%Part D<11 patientsGLP-1 receptor agonist1.8%Ozempic51%Wegovy49%Part D<11 patients+ 3 more classes in this area
Blood & clotting
8.8%Factor Xa inhibitor6.7%Eliquis100%Part D≥27 patientsP2Y12 inhibitor1.5%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy
Circulation Genomic and Precision Medicine
2026 - 26-CCC-16917-ACC NAVIGATING UNCHARTED WATERS: APICAL BALLOONING SYNDROME WHILST ON AFICAMTEN
Journal of the American College of Cardiology
2026 - Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
2025 - Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten
European Heart Journal - Case Reports
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Harvey Pass, MD
NYU Langone Health
Gareth Morgan, MD
NYU Langone Health
Douglas Kondziolka, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”